As the cannabis rescheduling process progresses and we enter the fourth quarter of 2024, many cannabis businesses are wondering what’s next and how rescheduling may impact 280E and tax planning.
In this session, Vicente...more
On August 27, 2024, nine vape shops operating in Allen, Texas were shut down after the Allen Police Department executed warrants in coordination with the Collin County Sheriff’s Office and the Federal Drug Enforcement...more
The historic US Drug Enforcement Administration (DEA) public comment period for marijuana's proposed rescheduling to Schedule III ended on July 22, 2024. Nearly 43,000 comments were submitted, which was the most comments ever...more
I recently traveled to Amsterdam to participate in an expert seminar on European cannabis and drug policy. The seminar covered various topics, including a thought experiment on where European Union (EU) cannabis reform was...more
7/26/2024
/ Agribusiness ,
Czech Republic ,
Decriminalization of Marijuana ,
EU ,
Germany ,
Malta ,
Marijuana ,
Marijuana Cultivation ,
Marijuana Related Businesses ,
Netherlands ,
Personal Use ,
Recreational Use ,
Switzerland ,
THC
On May 21, 2024, the DEA finally published its proposed rule related to rescheduling marijuana and commenced a 60-day period where the public can submit comments regarding DEA's proposed move to reschedule marijuana (the...more
5/22/2024
/ Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
International Treaties ,
Marijuana ,
Medical Marijuana ,
Office of Legal Counsel (OLC) ,
Proposed Rules ,
Public Comment ,
Schedule I Drugs ,
Scientific Research
After 50 years of being on the most restrictive schedule alongside drugs like heroin and PCP, the DEA will move to reschedule marijuana in Schedule III, where the plant’s medical benefits will finally be recognized by the...more
5/1/2024
/ Agribusiness ,
Controlled Substances Act ,
Corporate Counsel ,
DEA ,
Decriminalization of Marijuana ,
Department of Justice (DOJ) ,
Financial Services Industry ,
Food and Drug Administration (FDA) ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
Medical Research ,
Popular ,
Schedule I Drugs
After months of uncertainty, Germany’s parliament approved its scaled-back legalization/decriminalization bill, making Germany the third European country to legalize marijuana activities. While this bill does not go so far as...more
On August 29, 2023, the Department of Health and Human Services (“HHS”) sent the Drug Enforcement Administration (“DEA”) its recommendation to move marijuana from Schedule I to Schedule III of the Controlled Substances Act...more
On October 27, 2023, the Ninth Circuit Court of Appeals, in Aggarwal v. DEA, held that the U.S. Drug Enforcement Agency (DEA) must reconsider its denial of a petition to transfer psilocybin, the active ingredient in “magic...more
12/12/2023
/ Agricultural Sector ,
Controlled Substances ,
DEA ,
Department of Health and Human Services (HHS) ,
Drug Treatment ,
Food and Drug Administration (FDA) ,
Healthcare ,
Plant Based Products ,
Popular ,
Right to Try ,
Schedule I Drugs ,
Scientific Research
While the cannabis industry in the United States awaits a marijuana scheduling decision from the Drug Enforcement Agency (DEA), many countries around the world continue to move forward with liberalizing their cannabis...more
11/8/2023
/ Colombia ,
Controlled Substances Act ,
Czech Republic ,
DEA ,
Decriminalization of Marijuana ,
EU ,
Germany ,
Marijuana ,
Medical Marijuana ,
Popular ,
Recreational Use ,
Schedule I Drugs ,
Switzerland ,
Thailand ,
THC
Introduction-
The International Narcotics Control Board (“INCB”) released its “Report of the International Narcotics Control Board for 2022 (E/INCB/2022/1)” (the “Report”), which dedicates an entire section to discussing the...more
3/17/2023
/ Black Market ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Decriminalization of Marijuana ,
Health and Safety ,
Legalization ,
Marijuana ,
Medical Marijuana ,
Member State ,
Narcotics ,
Pharmaceutical Industry ,
Plant Based Products ,
Prescription Drugs ,
THC
In 2022 the California legislature passed Senate Bill 1326, now codified at Section 26301, et seq. of the California Business and Professions Code, authorizing California to enter into “agreement(s) with another state or...more
A recent paper by Kenzi Riboulet-Zemouli, published to coincide with the March 2022 session of the UN Commission on Narcotic Drugs (CND) in Vienna, purports to describe how regulating cannabis for recreational use...more